Compare · AMRO vs EW

AMRO vs EW

Side-by-side comparison of Amaero Inc. (AMRO) and Edwards Lifesciences Corporation (EW): market cap, price performance, sector, and recent activity on the wire.

Summary

  • AMRO operates in Industrials, while EW operates in Health Care - the two are in different parts of the market.
  • EW is the larger of the two at $58.73B, about 452.2x AMRO ($129.9M).
  • EW has hit the wire 8 times in the past 4 weeks while AMRO has been quiet.
  • EW has more recent analyst coverage (25 ratings vs 0 for AMRO).
MetricAMROEW
Company
Amaero Inc.
Edwards Lifesciences Corporation
Price
-
-
Market cap
$129.9M
$58.73B
1M return
-
-
1Y return
-
-
Industry
Industrial Specialties
Industrial Specialties
Exchange
NASDAQ
NYSE
IPO
2026
News (4w)
0
8
Recent ratings
0
25
AMRO

Amaero Inc.

Amaero Inc. is a leading U.S.-based producer of high-value refractory and titanium alloy spherical metal powders for additive manufacturing ('AM') and advanced manufacturing, and a pioneer in Powder Metallurgy Hot Isostatic Pressing ('PM-HIP') manufacturing of large near-net-shape components. With manufacturing and corporate headquarters in Tennessee, we occupy a strategically critical position at the intersection of U.S. national security priorities, including the rebuilding of a more resilient and scalable defense industrial base and the reshoring of sovereign manufacturing and supply chains.

EW

Edwards Lifesciences Corporation

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.